Rhythm Pharmaceuticals (RYTM) EBT Margin (2021 - 2026)
Rhythm Pharmaceuticals' (RYTM) quarterly EBT Margin came in at 91.65% in Q1 2026, up 5945.0% year-on-year from 1.52% in Q1 2025, and down 10.39% on a QoQ basis from 83.03% in Q4 2025.
Rhythm Pharmaceuticals (RYTM) EBT Margin (2021 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 6 years of EBT Margin data on file, last reported at 91.65% in Q1 2026.
- On a quarterly basis, EBT Margin rose 5945.0% year-over-year to 91.65% in Q1 2026; TTM through Mar 2026 was 92.89%, a 3028.0% increase from a year earlier, with the FY2025 full-year figure at 103.31%, up 9669.0% from the prior year.
- EBT Margin for Q1 2026 stood at 91.65%, down from 83.03% in the prior quarter.
- Over the last five years, EBT Margin for RYTM reached as high as 527.99% in Q4 2022 and fell as low as 3693.79% in Q1 2022.
- Historically, EBT Margin has averaged 418.76% across 5 years, with a median of 151.11% in 2025.
- On a YoY basis, EBT Margin climbed as much as 1422548 bps in 2022 and fell as far as 19156808 bps in 2022.
- Year by year, EBT Margin stood at 527.99% in 2022, then slumped by 132 bps to 170.99% in 2023, then surged by 39 bps to 103.71% in 2024, then increased by 20 bps to 83.03% in 2025, then decreased by 10 bps to 91.65% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 91.65% in Q1 2026, 83.03% in Q4 2025, and 102.91% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Rhythm Pharmaceuticals | 6.98 Bn | 6.64 Bn | 52.96 Mn | -91.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.65% |
| Dec 31, 2025 | -83.03% |
| Sep 30, 2025 | -102.91% |
| Jun 30, 2025 | -95.45% |
| Mar 31, 2025 | -151.11% |
| Dec 31, 2024 | -103.71% |
| Sep 30, 2024 | -132.28% |
| Jun 30, 2024 | -109.30% |
| Mar 31, 2024 | -543.27% |
| Dec 31, 2023 | -170.99% |
| Sep 30, 2023 | -194.61% |
| Jun 30, 2023 | -242.98% |
| Mar 31, 2023 | -454.96% |
| Dec 31, 2022 | 527.99% |
| Sep 30, 2022 | -953.80% |
| Jun 30, 2022 | -523.06% |
| Mar 31, 2022 | -3,693.79% |
| Dec 31, 2021 | -2,962.63% |
| Sep 30, 2021 | -4,602.14% |
| Jun 30, 2021 | -14,748.54% |